These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 31624333)
1. Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure? van Eijk RPA; Eijkemans MJC; Nikolakopoulos S; Jansen MD; Westeneng HJ; van Eijk KR; van der Spek RAA; van Vugt JJFA; Piepers S; Groeneveld GJ; Veldink JH; van den Berg LH; van Es MA Pharmacogenomics J; 2020 Apr; 20(2):220-226. PubMed ID: 31624333 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. van Eijk RPA; Jones AR; Sproviero W; Shatunov A; Shaw PJ; Leigh PN; Young CA; Shaw CE; Mora G; Mandrioli J; Borghero G; Volanti P; Diekstra FP; van Rheenen W; Verstraete E; Eijkemans MJC; Veldink JH; Chio A; Al-Chalabi A; van den Berg LH; van Es MA; Neurology; 2017 Oct; 89(18):1915-1922. PubMed ID: 28978660 [TBL] [Abstract][Full Text] [Related]
3. The Distinct Traits of the UNC13A Polymorphism in Amyotrophic Lateral Sclerosis. Tan HHG; Westeneng HJ; van der Burgh HK; van Es MA; Bakker LA; van Veenhuijzen K; van Eijk KR; van Eijk RPA; Veldink JH; van den Berg LH Ann Neurol; 2020 Oct; 88(4):796-806. PubMed ID: 32627229 [TBL] [Abstract][Full Text] [Related]
4. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature. Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717 [TBL] [Abstract][Full Text] [Related]
5. Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link? Trojsi F; D'Alvano G; Bonavita S; Tedeschi G Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455692 [TBL] [Abstract][Full Text] [Related]
6. High frequency of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis patients from two founder populations sharing the same risk haplotype. Goldstein O; Gana-Weisz M; Nefussy B; Vainer B; Nayshool O; Bar-Shira A; Traynor BJ; Drory VE; Orr-Urtreger A Neurobiol Aging; 2018 Apr; 64():160.e1-160.e7. PubMed ID: 29352617 [TBL] [Abstract][Full Text] [Related]
7. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)]. Tomiyama H Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305 [TBL] [Abstract][Full Text] [Related]
8. The frequency of the C9orf72 expansion in a Brazilian population. Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C; Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and genetic characterization of two dizygotic twins with C9orf72 expansion. Conforti FL; Tortelli R; Morello G; Capozzo R; Barulli MR; Cavallaro S; Logroscino G Neurobiol Aging; 2018 Sep; 69():293.e1-293.e8. PubMed ID: 29866399 [TBL] [Abstract][Full Text] [Related]